Blue Trust Inc. lessened its stake in Arcosa, Inc. (NYSE:ACA – Free Report) by 30.3% in the 4th quarter, HoldingsChannel reports. The fund owned 742 shares of the company’s stock after selling 323 shares during the quarter. Blue Trust Inc.’s holdings in Arcosa were worth $72,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACA. GAMMA Investing LLC grew its position in shares of Arcosa by 80.9% during the 4th quarter. GAMMA Investing LLC now owns 331 shares of the company’s stock worth $32,000 after buying an additional 148 shares during the period. Point72 DIFC Ltd bought a new position in Arcosa during the 3rd quarter worth approximately $37,000. KBC Group NV lifted its stake in Arcosa by 20.5% in the third quarter. KBC Group NV now owns 1,424 shares of the company’s stock valued at $135,000 after buying an additional 242 shares in the last quarter. First Trust Direct Indexing L.P. bought a new position in Arcosa in the third quarter valued at approximately $206,000. Finally, Sawgrass Asset Management LLC bought a new position in Arcosa in the third quarter valued at approximately $215,000. Institutional investors and hedge funds own 90.66% of the company’s stock.
Arcosa Trading Down 4.0 %
Shares of Arcosa stock opened at $92.79 on Monday. Arcosa, Inc. has a 52-week low of $72.75 and a 52-week high of $113.43. The firm has a 50-day moving average of $99.07 and a 200-day moving average of $96.83. The company has a debt-to-equity ratio of 0.51, a quick ratio of 2.77 and a current ratio of 3.61. The stock has a market cap of $4.53 billion, a PE ratio of 35.28 and a beta of 0.76.
Arcosa Announces Dividend
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on ACA shares. Oppenheimer boosted their price objective on shares of Arcosa from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 14th. Barclays initiated coverage on shares of Arcosa in a report on Tuesday, October 29th. They issued an “overweight” rating and a $106.00 price objective on the stock.
View Our Latest Stock Report on ACA
About Arcosa
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
Further Reading
- Five stocks we like better than Arcosa
- Which Wall Street Analysts are the Most Accurate?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Most active stocks: Dollar volume vs share volume
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Insider Trading – What You Need to Know
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.